Tidal Investments LLC Grows Stock Holdings in Baxter International Inc. $BAX

Tidal Investments LLC raised its holdings in Baxter International Inc. (NYSE:BAX) by 22.8% in the 2nd quarter, HoldingsChannel reports. The fund owned 164,400 shares of the medical instruments supplier’s stock after acquiring an additional 30,510 shares during the period. Tidal Investments LLC’s holdings in Baxter International were worth $3,505,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Baxter International in the second quarter valued at $1,744,874,000. Pzena Investment Management LLC purchased a new position in Baxter International during the second quarter worth about $1,392,098,000. California State Teachers Retirement System lifted its position in Baxter International by 2,009.1% during the second quarter. California State Teachers Retirement System now owns 12,720,343 shares of the medical instruments supplier’s stock worth $271,198,000 after buying an additional 12,117,222 shares during the period. Geode Capital Management LLC lifted its position in Baxter International by 7.8% during the fourth quarter. Geode Capital Management LLC now owns 13,510,205 shares of the medical instruments supplier’s stock worth $257,174,000 after buying an additional 972,891 shares during the period. Finally, Equity Investment Corp acquired a new stake in Baxter International in the 2nd quarter worth about $146,815,000. Hedge funds and other institutional investors own 90.19% of the company’s stock.

Baxter International Stock Performance

Baxter International stock opened at $23.84 on Tuesday. The firm has a market capitalization of $12.32 billion, a PE ratio of -11.51, a price-to-earnings-growth ratio of 3.60 and a beta of 0.60. Baxter International Inc. has a one year low of $15.73 and a one year high of $30.00. The stock’s 50 day moving average price is $25.01 and its 200 day moving average price is $20.86. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95.

Baxter International (NYSE:BAX) last issued its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.19. The company had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $2.80 billion. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. Baxter International’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter last year, the company earned $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. As a group, sell-side analysts expect that Baxter International Inc. will post 2.04 EPS for the current fiscal year.

Baxter International Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Friday, August 28th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, August 28th. Baxter International’s dividend payout ratio (DPR) is presently -1.93%.

Wall Street Analyst Weigh In

Several analysts have commented on the company. Stifel Nicolaus lifted their price target on Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. Weiss Ratings upgraded shares of Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, July 31st. Wells Fargo & Company raised their target price on shares of Baxter International from $19.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Zacks Research upgraded shares of Baxter International from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 11th. Finally, Wall Street Zen raised shares of Baxter International from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. Two analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $22.45.

Baxter International Company Profile

Baxter International Inc is a global healthcare company that develops and supplies medical products and technologies used in hospitals, outpatient facilities, physician offices and other care settings. Its offerings include intravenous therapy products and infusion systems, injectable medications and drug-compounding technologies, surgical products, patient-monitoring systems, respiratory-care equipment, and products used in hospital beds and connected-care environments.

The company serves healthcare providers and patients in numerous countries, with operations and customers across North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa.